Nurix Therapeutics, Inc.
News
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $27.00 Consensus PT from Brokerages
Ticker Report Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) have received an average recommendation of "Moderate Buy" from the thirteen research firms that are covering the company...\n more…
Robert W. Baird Initiates Coverage on Nurix Therapeutics (NASDAQ:NRIX)
Ticker Report Investment analysts at Robert W. Baird initiated coverage on shares of Nurix Therapeutics (NASDAQ:NRIX - Get Free Report) in a research note issued to investors on Friday, StockNewsAPI reports. The...\n more…
Unpleasant Surprises Could Be In Store For Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) Shares
Simply Wall St Nurix Therapeutics, Inc.'s ( NASDAQ:NRIX ) price-to-sales (or "P/S") ratio of 24.1x might make it look like a strong...\n more…
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
Globe Newswire SAN FRANCISCO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat...\n more…